P30L (p.Pro30Leu) variant of FBN2 (Fibrillin-2)

P30L (p.Pro30Leu) in FBN2 (Fibrillin-2) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data, published literature, and structural context.

P30L (p.Pro30Leu) variant details